Paclitaxel plus Cisplatin:standard regimen for first line treatment of advanced ovarian cancer[J]. Journal of Evidence-Based Medicine, 2004, 4(3): 167-168. DOI: 10.3969/j.issn.1671-5144.2004.03.013
|
Citation:
|
Paclitaxel plus Cisplatin:standard regimen for first line treatment of advanced ovarian cancer[J]. Journal of Evidence-Based Medicine, 2004, 4(3): 167-168. DOI: 10.3969/j.issn.1671-5144.2004.03.013
|
Paclitaxel plus Cisplatin:standard regimen for first line treatment of advanced ovarian cancer[J]. Journal of Evidence-Based Medicine, 2004, 4(3): 167-168. DOI: 10.3969/j.issn.1671-5144.2004.03.013
|
Citation:
|
Paclitaxel plus Cisplatin:standard regimen for first line treatment of advanced ovarian cancer[J]. Journal of Evidence-Based Medicine, 2004, 4(3): 167-168. DOI: 10.3969/j.issn.1671-5144.2004.03.013
|
DownLoad: